blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP Citations: EP3191120

Cited inInternational search
Type:Patent literature
Publication No.:WO2012082573  [XI]
 (NOVARTIS AG et al.)
Type:Patent literature
Publication No.:WO2006013107  [XDI]
 (NOVARTIS AG et al.)
Type:Patent literature
Publication No.:WO2013077907  [XI]
 (NOVARTIS AG et al.)
Type:Patent literature
Publication No.:WO2012045848  [A]
 (NOVARTIS AG et al.)
Type:Non-patent literature
Publication information:[XI]   RITA BARON-FAUST: "The IL-17 Superfamily: What Future for PsA? The IL-17 Superfamily: What Future for PsA?", RHEUMATOLOGY NETWORK, 18 March 2014 (2014-03-18), pages 1 - 5, XP055227427, Retrieved from the Internet [retrieved on 20151110]
Type:Non-patent literature
Publication information:[XI]   JOSHUA E WEITZ ET AL: "Ustekinumab: targeting the IL-17 pathway to improve outcomes in psoriatic arthritis", EXPERT OPINION ON BIOLOGICAL THERAPY, vol. 14, no. 4, 1 April 2014 (2014-04-01), ASHLEY, LONDON; GB, pages 515 - 526, XP055226577, ISSN: 1471-2598, DOI: 10.1517/14712598.2014.890587
DOI: http://dx.doi.org/10.1517/14712598.2014.890587
Type:Non-patent literature
Publication information:[XI]   PATEL DHAVALKUMAR D ET AL: "Effect of IL-17A blockade with secukinumab in autoimmune diseases", ANNALS OF THE RHEUMATIC DISEASES, B M J GROUP, GB, vol. 72, no. Suppl. 2, 1 April 2013 (2013-04-01), pages ii116 - ii123, XP009174221, ISSN: 1468-2060
DOI: http://dx.doi.org/10.1136/annrheumdis-2012-202371
Type:Non-patent literature
Publication information:[XI]   SARAH L. GAFFEN ET AL: "The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing", THE JOURNAL OF IMMUNOLOGY, vol. 14, no. 9, 22 August 2014 (2014-08-22), GB, pages 585 - 600, XP055227747, ISSN: 1474-1733, DOI: 10.1038/nri3707
DOI: http://dx.doi.org/10.1038/nri3707
Type:Non-patent literature
Publication information:[XI]   ALICE B GOTTLIEB ET AL: "AB0738 - Secukinumab Reduces Hscrp Levels in Subjects with Moderate-To-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis: A Sub-Analysis from the Phase 3 Erasure Study", ANNALS OF THE RHEUMATIC DISEASES, 1 January 2014 (2014-01-01), pages 1 - 1, XP055227757, Retrieved from the Internet [retrieved on 20151111], DOI: 10.1136/annrheumdis-2014-eular.1109
DOI: http://dx.doi.org/10.1136/annrheumdis-2014-eular.1109
Type:Non-patent literature
Publication information:[XI]   ALICE B. GOTTLIEB ET AL: "Secukinumab Shows Substantial Improvement In Both Psoriasis Symptoms and Physical Functioning In Moderate-To-Severe Plaque Psoriasis Patients With Psoriatic Arthritis: A Subanalysis Of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study", AMERICAN COLLEAGE OF RHEUMATOLOGY MEETING ABSTRACTS, 1 January 2013 (2013-01-01), pages 1 - 4, XP055227813, Retrieved from the Internet [retrieved on 20151111]
Type:Non-patent literature
Publication information:[XI]   MCINNES I ET AL: "Anti-Interleukin 17A Monoclonal Antibody Secukinumab Reduces Signs and Symptoms of Psoriatic Arthritis in a 24-Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial", ARTHRITIS & RHEUMATISM; 75TH ANNUAL SCIENTIFIC MEETING OF THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY/46TH ANNUAL SCIENTIFIC MEETING, WILEY, US; CHICAGO, IL, USA, vol. 63, no. Suppl. S10, 1 January 2011 (2011-01-01), pages S306, XP008147787, ISSN: 0004-3591, [retrieved on 20111209], DOI: 10.1002/ART.33310
DOI: http://dx.doi.org/10.1002/art.33310
Cited inOpposition
Type:Patent literature
Publication No.:WO2013077907  
Type:Patent literature
Publication No.:WO2012059598  
Type:Patent literature
Publication No.:WO2008156865  
Type:Patent literature
Publication No.:WO2016038538  
Type:Patent literature
Publication No.:US62048512  
Type:Non-patent literature
Publication information:  ALICE B. GOTTLIEB, BARDUR SIGURGEIRSSON, ANDREW BLAUVELT, SHEPHARD MPFOFU, RUVIE MARTIN AND CHARIS PAPAVASSILIS: "Secukinumab Shows Substantial Improvement In Both Psoriasis Symptoms and Physical Functioning In Moderate-To-Severe Plaque Psoriasis Patients With Psoriatic Arthritis: A Subanalysis Of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study", AMERICAN COLLEAGE OF RHEUMATOLOGY MEETING ABSTRACTS, pages 1 - 4, XP055227813, Retrieved from the Internet [retrieved on 20151111]
Type:Non-patent literature
Publication information:  ANONYMOUS: "Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) (FUTURE 1)", CLINICALTRIALS.GOV; NCT01392326, XP093254299, Retrieved from the Internet
Type:Non-patent literature
Publication information:  GOTTLIEB ALICE, LANGLEY RICHARD, PHILIPP SANDRA, MARTIN RUVIE, PAPAVASSILIS CHARIS, MPFOFU SHEPHARD: "Improvement in Psoriasis Symptoms and Physical Functioning with Secukinumab Compared with Placebo and Etanercept in Subjects with Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis: Results of a Subanalysis from the Phase 3 Fixture Study", 2013 ACR/ARHP ANNUAL MEETING, ABSTRACT L7, XP093254302, Retrieved from the Internet
Type:Non-patent literature
Publication information:  MCINNES IAIN B, SIEPER JOACHIM, BRAUN JRGEN, EMERY PAUL, VAN DER HEIJDE DSIRE, ISAACS JOHN D, DAHMEN GEORG, WOLLENHAUPT JRGEN,: "Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial", ANNALS OF THE RHEUMATIC DISEASES, vol. 73, no. 2, 1 February 2014 (2014-02-01), pages 349 - 356, XP009559708, ISSN: 0003-4967, DOI: 10.1136/annrheumdis-2012-202646
DOI: http://dx.doi.org/10.1136/annrheumdis-2012-202646
Type:Non-patent literature
Publication information:  PATEL DHAVALKUMAR D; LEE DAVID M; KOLBINGER FRANK; ANTONI CHRISTIAN: "Effect of IL-17A blockade with secukinumab in autoimmune diseases.", ANNALS OF THE RHEUMATIC DISEASES, B M J GROUP, GB, vol. 72, no. Suppl. 2, 1 April 2013 (2013-04-01), GB , pages ii116 - ii123, XP009174221, ISSN: 1468-2060, DOI: 10.1136/annrheumdis-2012-202371
DOI: http://dx.doi.org/10.1136/annrheumdis-2012-202371
Type:Non-patent literature
Publication information:  GISONDI PAOLO, DALLE VEDOVE CAMILLA, GIROLOMONI GIAMPIERO: "Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy", DERMATOLOGY AND THERAPY, vol. 4, no. 1, 1 June 2014 (2014-06-01), pages 1 - 9, XP093254308, ISSN: 2193-8210, DOI: 10.1007/s13555-014-0042-5
Type:Non-patent literature
Publication information:  BRUCE W. KIRKHAM, ARTHUR KAVANAUGH, KRISTIAN REICH: "Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis", CANCER RESEARCH, WILEY-BLACKWELL PUBLISHING LTD., GB, vol. 141, no. 2, 9 February 2014 (2014-02-09), GB , pages 133 - 142, XP055303103, ISSN: 0019-2805, DOI: 10.1111/imm.12142
DOI: http://dx.doi.org/10.1111/imm.12142
Type:Non-patent literature
Publication information:  MARINONI BEATRICE; CERIBELLI ANGELA; MASSAROTTI MARCO S.; SELMI CARLO: "The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications", AUTOIMMUNITY HIGHLIGHTS, SPRINGER INTERNATIONAL PUBLISHING, CHAM, vol. 5, no. 1, 22 January 2014 (2014-01-22), Cham , pages 9 - 19, XP035980848, ISSN: 2038-0305, DOI: 10.1007/s13317-013-0057-4
DOI: http://dx.doi.org/10.1007/s13317-013-0057-4
Type:Non-patent literature
Publication information:  PHILIP J. MEASE, ARMSTRONG APRIL W.: "Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis", DRUGS, ADIS INTERNATIONAL LTD., NZ, vol. 74, no. 4, 1 March 2014 (2014-03-01), NZ , pages 423 - 441, XP055411681, ISSN: 0012-6667, DOI: 10.1007/s40265-014-0191-y
DOI: http://dx.doi.org/10.1007/s40265-014-0191-y
Type:Non-patent literature
Publication information:  SCHETT GEORG, COATES LAURA C, ASH ZOE R, FINZEL STEFANIE, CONAGHAN PHILLIP G: "Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future", ARTHRITIS RESEARCH AND THERAPY, BIOMED CENTRAL, LONDON, GB, vol. 13, no. S1, 1 December 2011 (2011-12-01), GB , XP093254311, ISSN: 1478-6354, DOI: 10.1186/1478-6354-13-S1-S4
Type:Non-patent literature
Publication information:  SUZUKI ERIKA, MELLINS ELIZABETH D., GERSHWIN M. ERIC, NESTLE FRANK O., ADAMOPOULOS IANNIS E.: "The IL-23/IL-17 axis in psoriatic arthritis", AUTOIMMUNITY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 13, no. 4-5, 1 April 2014 (2014-04-01), NL , pages 496 - 502, XP093254313, ISSN: 1568-9972, DOI: 10.1016/j.autrev.2014.01.050
Type:Non-patent literature
Publication information:  BINA MENON; NICOLA J. GULLICK; GINA J. WALTER; MEGHA RAJASEKHAR; TOBY GARROOD; HAYLEY G. EVANS; LEONIE S. TAAMS; BRUCE W. KIRKHAM: "Interleukin17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression", ARTHRITIS & RHEUMATOLOGY, JOHN WILEY & SONS, INC., US, vol. 66, no. 5, 28 April 2014 (2014-04-28), US , pages 1272 - 1281, XP072275342, ISSN: 2326-5191, DOI: 10.1002/art.38376
DOI: http://dx.doi.org/10.1002/art.38376
Type:Non-patent literature
Publication information:  H HUANG, H J KIM, E-J CHANG, Z H LEE, S J HWANG, H-M KIM, Y LEE, H-H KIM: "IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling", CELL DEATH & DIFFERENTIATION, NATURE PUBLISHING GROUP, GB, vol. 16, no. 10, 19 October 2009 (2009-10-19), GB , pages 1332 - 1343, XP055259952, ISSN: 1350-9047, DOI: 10.1038/cdd.2009.74
DOI: http://dx.doi.org/10.1038/cdd.2009.74
Type:Non-patent literature
Publication information:  ANONYMOUS: "Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis (FUTURE 2)", CLINICALTRIALS.GOV; NCT01752634, XP093254323, Retrieved from the Internet
Type:Non-patent literature
Publication information:  KAVANAUGH A, RITCHLIN C, RAHMAN P, PUIG L, GOTTLIEB AB, LI S, WANG Y, NOONAN L, BRODMERKEL C,: "Ustekinumab, an anti- IL -12/23 p40 monoclonal antibody, inhibits 1 radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials", ANNALS OF THE RHEUMATIC DISEASES, vol. 73, no. 6, 19 February 2014 (2014-02-19), pages 1000 - 1006, XP009514326, ISSN: 0003-4967, DOI: 10.1136/annrheumdis-2013-204741
DOI: http://dx.doi.org/10.1136/annrheumdis-2013-204741
Type:Non-patent literature
Publication information:  ALICE B GOTTLIEB, B. SIGURGEIRSSON, A. BLAUVELT, Y. GONG, C. PAPAVASSILIS, S. MPOFU: "AB0738 Secukinumab Reduces Hscrp Levels in Subjects with Moderate-To-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis: A Sub-Analysis from the Phase 3 Erasure Study", ANNALS OF THE RHEUMATIC DISEASES, pages 1 - 1, XP055227757, Retrieved from the Internet [retrieved on 20151111], DOI: 10.1136/annrheumdis-2014-eular.1109
DOI: http://dx.doi.org/10.1136/annrheumdis-2014-eular.1109
Type:Non-patent literature
Publication information:  VAN DER HEIJDE, SHARP J, WASSENBERG S, GLADMAN D D: "Psoriatic arthritis imaging: a review of scoring methods", ANNALS OF THE RHEUMATIC DISEASES, vol. 64, 1 March 2005 (2005-03-01), pages ii61 - ii64, XP093254330, ISSN: 0003-4967, DOI: 10.1136/ard.2004.030809
DOI: http://dx.doi.org/10.1136/ard.2004.030809
Type:Non-patent literature
Publication information:  MCINNES IAIN B, MEASE PHILIP J, KIRKHAM BRUCE, KAVANAUGH ARTHUR, RITCHLIN CHRISTOPHER T, RAHMAN PROTON, VAN DER HEIJDE DéSIR&: "Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial", THE LANCET, ELSEVIER, AMSTERDAM, NL, vol. 386, no. 9999, 1 September 2015 (2015-09-01), AMSTERDAM, NL , pages 1137 - 1146, XP055816435, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(15)61134-5
DOI: http://dx.doi.org/10.1016/S0140-6736(15)61134-5
Type:Non-patent literature
Publication information:  ANONYMOUS: "Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) (FUTURE 1)", CLINICALTRIALS.GOV; NCT01392326, XP093254332, Retrieved from the Internet
Type:Non-patent literature
Publication information:  HELLIWELL PHILIP, LAURA COATES: "Interleukin-17 inhibition in psoriatic arthritis", vol. 386, no. 9999, 19 September 2015 (2015-09-19), pages 1114 - 1116, XP093254338, DOI: 10.1016/S0140-6736(15)60497-4
Type:Non-patent literature
Publication information:  S. RAMIRO, J.S. SMOLEN, R. LANDEW, D. VAN DER HEIJDE, M. DOUGADOS, P. EMERY, M. DE WIT, M. CUTOLO, S. OLIVER, L. GOSSEC: "THU0412Pharmacological Treatment of Psoriatic Arthritis (PSA): Systematic Literature Review for the Update of the Eular Recommendations for the Management of PSA", ANNALS OF THE RHEUMATIC DISEASES; POSTER PRESENTATIONS - PSORIATIC ARTHRITIS, vol. 74, no. 2, 1 January 2015 (2015-01-01), pages 346, XP009559709, DOI: 10.1136/annrheumdis-2015-eular.4236
Type:Non-patent literature
Publication information:  DAVID T. FELSON, JENNIFER J. ANDERSON, MAARTEN BOERS, CLAIRE BOMBARDIER, DANIEL FURST, CHARLES GOLDSMITH, LINDA M. KATZ, ROBERT LI: "American college of rheumatology preliminary definition of improvement in rheumatoid arthritis", ARTHRITIS & RHEUMATISM, J.B. LIPPINCOTT CO., vol. 38, no. 6, 1 June 1995 (1995-06-01), pages 727 - 735, XP055047068, ISSN: 00043591, DOI: 10.1002/art.1780380602
DOI: http://dx.doi.org/10.1002/art.1780380602
Type:Non-patent literature
Publication information:  ANONYMOUS: "GUIDELINE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF PSORIATIC ARTHRITIS ", EMEA, EUROPEAN MEDICINES AGENCY; COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP); DOC. REF. CHMP/EWP/438/04, XP093254355, Retrieved from the Internet
Type:Non-patent literature
Publication information:  GOTTLIEB, A. ; KORMAN, N.J. ; GORDON, K.B. ; FELDMAN, S.R. ; LEBWOHL, M. ; KOO, J.Y.M. ; VAN VOORHEES, A.S. ; ELMETS, C.A. ; LEONA: "Guidelines of care for the management of psoriasis and psoriatic arthritis", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY, INC, US, vol. 58, no. 5, 1 May 2008 (2008-05-01), US , pages 851 - 864, XP022609137, ISSN: 0190-9622, DOI: 10.1016/j.jaad.2008.02.040
DOI: http://dx.doi.org/10.1016/j.jaad.2008.02.040
Type:Non-patent literature
Publication information:  ORY P A, GLADMAN D D, MEASE P J: "Psoriatic arthritis and imaging", ANNALS OF THE RHEUMATIC DISEASES, vol. 64, 1 March 2005 (2005-03-01), pages ii55 - ii57, XP093254359, ISSN: 0003-4967, DOI: 10.1136/ard.2004.033928
DOI: http://dx.doi.org/10.1136/ard.2004.033928
Type:Non-patent literature
Publication information:  MEASE PHILIP J: "Assessment Tools in Psoriatic Arthritis", THE JOURNAL OF RHEUMATOLOGY, vol. 35, no. 7, 1 January 2008 (2008-01-01), pages 1426 - 1430, XP093254361
Type:Non-patent literature
Publication information:  FITZGERALD OLIVER, RITCHLIN CHRISTOPHER T., MEASE PHILIP J.: "Biomarkers of Radiographic Progression in Psoriatic Arthritis: A Report from the GRAPPA 2011 Annual Meeting", JOURNAL OF RHEUMATOLOGY, JOURNAL OF RHEUMATOLOGY PUBLISHING COMPANY., CA, vol. 39, no. 11, 1 November 2012 (2012-11-01), CA , pages 2189 - 2192, XP093254365, ISSN: 0315-162X, DOI: 10.3899/jrheum.120820
DOI: http://dx.doi.org/10.3899/jrheum.120820
Type:Non-patent literature
Publication information:  RICHARD G. LANGLEY, BONI E. ELEWSKI, MARK LEBWOHL, KRISTIAN REICH, CHRISTOPHER E.M. GRIFFITHS, KIM PAPP, LLUS PUIG, HIDEMI NAKAGA: "Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials", THE NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 371, no. 4, 24 July 2014 (2014-07-24), US , pages 326 - 338, XP055414280, ISSN: 0028-4793, DOI: 10.1056/NEJMoa1314258
DOI: http://dx.doi.org/10.1056/NEJMoa1314258
Type:Non-patent literature
Publication information:  D38a - Supplementary material of D15 (trial protocol)
Type:Non-patent literature
Publication information:  VAN DER HEIJDE DSIRE, LANDEW ROBERT B M, MEASE PHILIP J, MCINNES IAIN B, CONAGHAN PHILIP G, PRICOP LUMINITA, LIGOZIO GREGORY, R: "Secukinumab, a Monoclonal Antibody to Interleukin-17A, Provides Signicant and Sustained Inhibition of Joint Structural Damage in Active Psoriatic Arthritis Regardless of Prior TNF Inhibitors or Concomitant Methotrexate: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study", ABSTRACT NUMBER: 954, 2014 ACR/ARHP ANNUAL MEETING, XP093254374, Retrieved from the Internet
Type:Non-patent literature
Publication information:  VAN DER HEIJDE, KAVANAUGH A., GLADMAN D. D., ANTONI C., KRUEGER G. G., GUZZO C., ZHOU B., DOOLEY L. T., DE VLAM K., GEUSENS P., BI: "Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2", ARTHRITIS & RHEUMATISM, WILEY INTERSCIENCE, US, vol. 56, no. 8, 1 August 2007 (2007-08-01), US , pages 2698 - 2707, XP093254376, ISSN: 0004-3591, DOI: 10.1002/art.22805
DOI: http://dx.doi.org/10.1002/art.22805
Type:Non-patent literature
Publication information:  ANTONI C, KRUEGER G G, DE VLAM K, BIRBARA C, BEUTLER A, GUZZO C, ZHOU B, DOOLEY L T, KAVANAUGH A: "Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial", ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP LTD AND EUROPEAN LEAGUE AGAINST RHEUMATISM, LONDON, vol. 64, no. 8, 1 August 2005 (2005-08-01), London, pages 1150 - 1157, XP009559762, ISSN: 0003-4967, DOI: 10.1136/ard.2004.032268
DOI: http://dx.doi.org/10.1136/ard.2004.032268
Type:Non-patent literature
Publication information:  KAVANAUGH ARTHUR, VAN DER HEIJDE DSIRE, MCINNES IAIN B., MEASE PHILIP, KRUEGER GERALD G., GLADMAN DAFNA D., GMEZREINO JUAN, PA: "Golimumab in psoriatic arthritis: Oneyear clinical efficacy, radiographic, and safety results from a phase III, randomized, placebocontrolled trial", ARTHRITIS & RHEUMATISM, WILEY INTERSCIENCE, US, vol. 64, no. 8, 1 August 2012 (2012-08-01), US , pages 2504 - 2517, XP093254377, ISSN: 0004-3591, DOI: 10.1002/art.34436
DOI: http://dx.doi.org/10.1002/art.34436
Type:Non-patent literature
Publication information:  MCINNES IAIN B, KAVANAUGH ARTHUR, GOTTLIEB ALICE B, PUIG LLUS, RAHMAN PROTON, RITCHLIN CHRISTOPHER, BRODMERKEL CARRIE, LI SHU, WA: "Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial", THE LANCET, vol. 382, no. 9894, 1 August 2013 (2013-08-01), pages 780 - 789, XP093254379, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(13)60594-2
DOI: http://dx.doi.org/10.1016/S0140-6736(13)60594-2
Type:Non-patent literature
Publication information:  HEIJDE DSIRE VAN, LANDEW ROBERT, KLARESKOG LARS, RODRGUEZVALVERDE VICENTE, SETTAS LUCAS, PEDERSEN RONALD, FATENEJAD SAEED: "Presentation and analysis of data on radiographic outcome in clinical trials: Experience from the TEMPO study", ARTHRITIS & RHEUMATISM, WILEY INTERSCIENCE, US, vol. 52, no. 1, 1 January 2005 (2005-01-01), US , pages 49 - 60, XP093254382, ISSN: 0004-3591, DOI: 10.1002/art.20775
DOI: http://dx.doi.org/10.1002/art.20775
Type:Non-patent literature
Publication information:  L GOSSEC, J S SMOLEN, C GAUJOUX-VIALA, Z ASH, H MARZO-ORTEGA, D VAN DER HEIJDE, O FITZGERALD, D ALETAHA, P BALINT, D BOUMPAS, J BR: "European League against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies", ANNALS OF THE RHEUMATIC DISEASES, B M J GROUP, GB, vol. 71, no. 1, 1 January 2012 (2012-01-01), GB , pages 4 - 12, XP009559720, ISSN: 1468-2060, DOI: 10.1136/annrheumdis-2011-200350
Type:Non-patent literature
Publication information:  COMBE BERNARD: "Update on the use of etanercept across a spectrum of rheumatoid disorders", BIOLOGICS: TARGETS AND THERAPY, DOVE MEDICAL PRESS, NZ, NZ , pages 165, XP093254386, ISSN: 1177-5475, DOI: 10.2147/BTT.S1379
DOI: http://dx.doi.org/10.2147/BTT.S1379
Type:Non-patent literature
Publication information:  MEASE P J, ORY P, SHARP J T, RITCHLIN C T, VAN DEN BOSCH F, WELLBORNE F, BIRBARA C, THOMSON G T D, PERDOK R J, MEDICH J, WONG R L,: "Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)", ANNALS OF THE RHEUMATIC DISEASES, vol. 68, no. 5, 1 May 2009 (2009-05-01), pages 702 - 709, XP093254388, ISSN: 0003-4967, DOI: 10.1136/ard.2008.092767
DOI: http://dx.doi.org/10.1136/ard.2008.092767
Type:Non-patent literature
Publication information:  ANONYMOUS: "Cosentyx - Summary of Product Characteristics", EMA, 1 January 2015 (2015-01-01), XP093281199
Type:Non-patent literature
Publication information:  "Field Trials of Health Interventions: A Toolbox. 3rd edition", 1 June 2015, OUP OXFORD, article ANONYMOUS: "Chapter 12 Outcome measures and case definition", XP093301352
Type:Non-patent literature
Publication information:  LI GUOWEI, TALJAARD MONICA, VAN DEN HEUVEL EDWIN R., LEVINE MITCHELL AH., COOK DEBORAH J., WELLS GEORGE A., DEVEREAUX PHILIP J., T: "An introduction to multiplicity issues in clinical trials: the what, why, when and how", INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIVERSITY PRESS, GB, GB , pages dyw320, XP093301354, ISSN: 0300-5771, DOI: 10.1093/ije/dyw320
Cited inby applicant
Type:Patent literature
Publication No.:WO2006013107  
Type:Patent literature
Publication No.:WO2007117749  
Type:Patent literature
Publication No.:US7767206  
Type:Patent literature
Publication No.:WO2008054603  
Type:Patent literature
Publication No.:US8057794  
Type:Patent literature
Publication No.:US8003099  
Type:Patent literature
Publication No.:US8110191  
Type:Patent literature
Publication No.:US7838638  
Type:Patent literature
Publication No.:US2012034656  
Type:Patent literature
Publication No.:US2011027290  
Type:Patent literature
Publication No.:US2011064307  
Type:Non-patent literature
Publication information:  BOEHNCKE; MENTER, AM J CLIN DERMATOL, vol. 14, 2013, pages 377 - 88
Type:Non-patent literature
Publication information:  GLADMAN ET AL., ANN RHEUM DIS., vol. 64, no. 2, 2005, pages II14 - 17
Type:Non-patent literature
Publication information:  MEASE PJ ET AL.: "Primer on Rheumatic Diseases. 13th ed.", 2008, SPRINGER SCIENCE, article "Psoriatic Arthritis", pages: 170 - 192
Type:Non-patent literature
Publication information:  MEASE, CURR OPIN RHEUMATOL., vol. 25, 2013, pages 287 - 96
Type:Non-patent literature
Publication information:  MEASE; ARMSTRONG, DRUGS, vol. 74, 2014, pages 423 - 41
Type:Non-patent literature
Publication information:  GOSSEC ET AL., ANN RHEUM DIS, vol. 71, 2012, pages 4 - 12
Type:Non-patent literature
Publication information:  MENTER ET AL., J AM ACAD DERMATOL, vol. 65, 2011, pages 137 - 74
Type:Non-patent literature
Publication information:  GLADMAN ET AL., ANN RHEUM DIS., vol. 64, no. 2, 2005, pages IIL4 - 17
Type:Non-patent literature
Publication information:  KAVANAUGH ET AL., ANN. RHEUM. DIS., vol. 73, 2014, pages 1000 - 1006
Type:Non-patent literature
Publication information:  JANDUS, ARTHRITIS RHEUM, vol. 58, 2008, pages 2307 - 17
Type:Non-patent literature
Publication information:  KAGAMI, J INVEST DERMATOL, vol. 130, 2010, pages 1373 - 83
Type:Non-patent literature
Publication information:  LIN, J IMMUNOL, vol. 187, 2011, pages 490 - 500
Type:Non-patent literature
Publication information:  NOORDENBOS, ARTHRITIS RHEUM, vol. 64, 2012, pages 99 - 109
Type:Non-patent literature
Publication information:  MENON ET AL., ARTHRITIS RHEUMATOL., vol. 66, 2014, pages 1272 - 81
Type:Non-patent literature
Publication information:  MCINNES ET AL., ANN RHEUM DIS, vol. 73, 2014, pages 349 - 56
Type:Non-patent literature
Publication information:  MEASE ET AL., N ENGL J MED, vol. 370, 2014, pages 2295 - 306
Type:Non-patent literature
Publication information:  VAN DER HEIJDE, ANN. RHEUM. DIS., vol. 64, 2005, pages II61 - II64
Type:Non-patent literature
Publication information:  WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546
Type:Non-patent literature
Publication information:  BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426
Type:Non-patent literature
Publication information:  HUSTON ET AL., PROC. NATL. ACAD. SCI., vol. 85, 1988, pages 5879 - 5883
Type:Non-patent literature
Publication information:  HWANG ET AL., ARTHRITIS RES THER, vol. 6, 2004, pages R120 - 128
Type:Non-patent literature
Publication information:  ALTSHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 410
Type:Non-patent literature
Publication information:  NEEDLEMAN ET AL., J. MOL. BIOL., vol. 48, 1970, pages 444 453
Type:Non-patent literature
Publication information:  MEYERS ET AL., COMPUT. APPL. BIOSCI., vol. 4, 1988, pages 11 17
Type:Non-patent literature
Publication information:  E. MEYERS; W. MILLER, CABIOS, vol. 4, 1989, pages 11 - 17
Type:Non-patent literature
Publication information:  MROWIETZ ET AL., ARCH. DERMATOL. RES., vol. 303, 2011, pages 1 - 10
Type:Non-patent literature
Publication information:  KABAT E.A. ET AL.: "Sequences of Proteins of Immunological Interest", NATIONAL INSTITUTE OF HEALTH
Type:Non-patent literature
Publication information:  TAYLOR WET, ARTHRITIS RHEUM, vol. 54, 2006, pages 2665 - 73
Type:Non-patent literature
Publication information:  CLEGG ET AL., ARTHRITIS RHEUM, vol. 39, 1996, pages 2013 - 20
Type:Non-patent literature
Publication information:  FELDMAN; KRUEGER, ANN. RHEUM. DIS., vol. 64, 2005, pages II65 - II68
Type:Non-patent literature
Publication information:  ALETAHA D; SMOLEN J, CLIN.EXP.RHEUMATOL, vol. 23, no. 5, 2005, pages S100 - S108
Type:Non-patent literature
Publication information:  ALETAHA, ARTHRITIS RHEUM., vol. 52, no. 9, 2005, pages 2625 - 36
Type:Non-patent literature
Publication information:  HEUFT- DORENBOSCH L ET AL., ANN RHEUM DIS, vol. 62, 2003, pages 127 - 32
Type:Non-patent literature
Publication information:  GLADMAN DD, CURR RHEUMATOL REP, vol. 9, 2007, pages 455 - 60
Type:Non-patent literature
Publication information:  MAKSYMOWYCH ET AL., J. RHEUMATOLOGY, vol. 30, 2003, pages 1356 - 63
Type:Non-patent literature
Publication information:  HELLIWELL ET AL., J RHEUMATOL, vol. 32, 2005, pages 1745 - 50
Type:Non-patent literature
Publication information:  TAYLOR ET AL., ARTHRITIS RHEUM, vol. 38, 2006, pages 727 - 35
Type:Non-patent literature
Publication information:  FELSON ET AL., ARTHRITIS RHEUM, vol. 38, 1995, pages 727 - 35
Type:Non-patent literature
Publication information:  WEISMAN ET AL., J DERMATOLOG TREAT., vol. 14, 2003, pages 158 - 65
Type:Non-patent literature
Publication information:  WELLS ET AL., ANN REHUM DIS, vol. 68, 2009, pages 954 - 60
Type:Non-patent literature
Publication information:  WARE ET AL., MED CARE, vol. 30, 1992, pages 473 - 83
Type:Non-patent literature
Publication information:  FRIES ET AL., ARTHRITIS RHEUM, vol. 23, 1980, pages 137 - 45
Type:Non-patent literature
Publication information:  VAN DER HEIJDE ET AL., ARTHRITIS RHEUM, vol. 52, 2005, pages 49 - 60
Type:Non-patent literature
Publication information:  GOULABCHAND ET AL., ANN RHEUM DIS, vol. 73, 2014, pages 414 - 9
Type:Non-patent literature
Publication information:  MEASE ET AL., DRUGS, vol. 74, 2014, pages 423 - 41
Type:Non-patent literature
Publication information:  SAAD ET AL., ARTHRITIS RES THER, vol. 11, 2009, pages R52
Type:Non-patent literature
Publication information:  FAGERLI ET AL., ANN RHEUM DIS, vol. 72, 2013, pages 1840 - 4